PD-L1 expression on tumor-infiltrating immune cells (ICs) was assessed by immunohistochemistry, with categories defined by percentage of positive cells: IC0 (<1%), IC1 (≥1% but <5%), and IC2/3 (≥5%) [12]. The gene discussed is CD274; the disease is neoplasm.